Detalhe da pesquisa
1.
Adherence in Hepatitis C Virus Treatment: What We Know.
Semin Liver Dis
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657680
2.
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis.
Am J Gastroenterol
; 119(1): 107-115, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011138
3.
AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
Clin Gastroenterol Hepatol
; 20(12): 2707-2716, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075500
4.
The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
Liver Transpl
; 27(8): 1191-1202, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33848394
5.
Safety and Efficacy of Segmental Yttrium-90 Radioembolization for Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt Creation.
J Vasc Interv Radiol
; 32(2): 211-219, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33349507
6.
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
N Engl J Med
; 376(22): 2134-2146, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28564569
7.
Reply.
Clin Gastroenterol Hepatol
; 22(2): 436-437, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543100
8.
No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12â¯weeks in HCV DAA-experienced patients.
J Hepatol
; 69(6): 1221-1230, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30098373
9.
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
N Engl J Med
; 373(27): 2618-28, 2015 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26569658
10.
Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment.
Hepatology
; 66(2): 389-397, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28128852
11.
Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
J Hepatol
; 66(6): 1173-1181, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28161470
12.
Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study.
Hepatology
; 64(6): 1893-1899, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27533287
13.
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
Gastroenterology
; 149(3): 649-59, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25985734
14.
To Transplant or Not to Transplant: Understanding and Assessing the Liver-Kidney Allocation Policy.
Liver Transpl
; 27(11): 1527-1528, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273226
15.
Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C virus retreatment in decompensated cirrhosis.
Liver Int
; 41(12): 3024-3027, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592051
16.
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial.
Ann Intern Med
; 163(11): 809-17, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26551263
17.
Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity.
J Clin Gastroenterol
; 49(4): 336-44, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24828357
18.
Rates of recurrent variceal bleeding are low with modern esophageal banding strategies: a retrospective cohort study.
Scand J Gastroenterol
; 50(9): 1059-67, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25865440
19.
Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials.
J Hepatol
; 61(2): 200-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24747798
20.
Response-guided telaprevir combination treatment for hepatitis C virus infection.
N Engl J Med
; 365(11): 1014-24, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21916639